EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Are circadian rhythms more favorable with lithium than with other mood stabilizers? An exploratory actigraphy study in euthymic bipolar disorder type 1

Vincent Hennion, Jan Scott, Victoire Martinot, Chloé Benizri, Cynthia Marie-Claire, Frank Bellivier, Bruno Etain

Comprehensive Psychiatry · 2024-11 · 135 · 152531

DOI: 10.1016/j.comppsych.2024.152531 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comprehensive Psychiatry, 2024-11. Verfasst von Vincent Hennion und 6 weiteren Autor:innen. Beteiligte Einrichtung: Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM U1144, Université Paris Cité, Paris, France; AP-HP Nord, GH Saint-Louis-Lariboisière-F…. Hauptthemen laut MEDLINE: Bipolar Disorder, Actigraphy, Circadian Rhythm, Antimanic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Institut National de la Santé et de la Recherche Médicale, Assistance Publique - Hôpitaux de Paris.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Bipolar Disorder (BD) is associated with alterations of circadian rhythms of activity (CRA). Experimental research suggests that lithium (Li) modifies CRA, but this has been rarely explored in BD using actigraphy. METHODS: The sample comprised 88 euthymic BD-I cases with 3 weeks of actigraphy. We used a Principal Component Analysis (PCA) to generate CRA dimensions. We then used linear regression analyses to compare these dimensions between groups of individuals defined according to prescribed mood stabilizers: Li monotherapy ("Li" group, n = 28), anticonvulsant or atypical antipsychotic monotherapy ("AC or AAP" group, n = 27) or combined treatments ("Li+AC or Li+AAP" group, n = 33). Analyses were adjusted for potential confounders (gender, age, body mass index, depressive symptoms, co-prescribed benzodiazepines and antidepressants, smoking status and past alcohol use disorder). RESULTS: The PCA identified two dimensions: "robust CRA" (high amplitude and interdaily stability, with low intradaily variability) and "late chronotype". Univariate analyses showed higher scores for "robust CRA" in the "Li" versus the "AC or AAP" (p = 0.021) or "Li+AC or Li+AAP" groups (p = 0.047). These findings remained significant after adjustments (respectively p = 0.010 and p = 0.019). Post-hoc analyses suggested lower variability, higher stability and higher amplitude of CRA in the "Li" group. Medication groups were similar for the "late chronotype" dimension (p = 0.92). CONCLUSIONS: This actigraphy study is the first to show more favorable CRA in BD-I individuals receiving a Li monotherapy when compared with those receiving other classes or combinations of mood stabilizers. Replications in larger samples are required. Prospective studies are also warranted to elucidate whether the introduction of Li or other mood stabilizers might influence CRA in BD-I.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderActigraphyCircadian RhythmAntimanic AgentsAntipsychotic AgentsHumansFemaleMaleAdultMiddle AgedAnticonvulsantsLithium CompoundsAntidepressive AgentsLithium

Stichwörter der Autor:innen

ActigraphyActivityAnticonvulsantAtypical antipsychoticBipolar disorderCircadian rhythmLithium

Substanzen

Antimanic AgentsAntipsychotic AgentsAnticonvulsantsLithium CompoundsAntidepressive AgentsLithium

Autor:innen und Institutionen

  • Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM U1144, Université Paris Cité, Paris, France; AP-HP Nord, GH Saint-Louis-Lariboisière-Fernand-Widal, DMU Neurosciences, Département de Psychiatrie et de Méde…
  • Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM U1144, Université Paris Cité, Paris, France; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
  • Établissement de SantÉ Mentale de Paris et Ivry-sur-Seine, Groupe MGEN, Paris, France.
  • Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM U1144, Université Paris Cité, Paris, France.

Förderung

  • Institut National de la Santé et de la Recherche Médicale
  • Assistance Publique - Hôpitaux de Paris

Zitieren

APA

Hennion, V., Scott, J., Martinot, V., Benizri, C., Marie-Claire, C., Bellivier, F., & Etain, B. (2024). Are circadian rhythms more favorable with lithium than with other mood stabilizers? An exploratory actigraphy study in euthymic bipolar disorder type 1. Comprehensive Psychiatry, 135, 152531. https://doi.org/10.1016/j.comppsych.2024.152531

Vancouver

Hennion V, Scott J, Martinot V, Benizri C, Marie-Claire C, Bellivier F, et al. Are circadian rhythms more favorable with lithium than with other mood stabilizers? An exploratory actigraphy study in euthymic bipolar disorder type 1. Comprehensive Psychiatry. 2024;135:152531. doi:10.1016/j.comppsych.2024.152531

BibTeX
@article{Hennion2024,
  author = {Hennion, Vincent and Scott, Jan and Martinot, Victoire and Benizri, Chloé and Marie-Claire, Cynthia and Bellivier, Frank and Etain, Bruno},
  title = {Are circadian rhythms more favorable with lithium than with other mood stabilizers? An exploratory actigraphy study in euthymic bipolar disorder type 1},
  journal = {Comprehensive Psychiatry},
  year = {2024},
  volume = {135},
  pages = {152531},
  doi = {10.1016/j.comppsych.2024.152531}
}
Kostenlos starten →